Anagenex Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Out of Business

Anagenex General Information

Description

Operator of an AI-driven drug discovery platform intended to develop small-molecule therapeutics. The company combines ultra-high-throughput biochemistry, DNA-encoded library technology, directed evolution, and machine learning to identify and optimize compounds against disease-associated protein targets, enabling pharmaceutical companies to accelerate small-molecule drug discovery.

Contact Information

Website
www.anagenex.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 20 Maguire Road
  • Suite 302
  • Lexington, MA 02421
  • United States
+1 (978)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 20 Maguire Road
  • Suite 302
  • Lexington, MA 02421
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anagenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 26-Sep-2025 Completed Out of Business
4. Early Stage VC Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series A) 15-Apr-2022 $30M $37.2M Completed Generating Revenue
1. Seed Round 19-Dec-2019 $7.2M $7.2M Completed Generating Revenue
To view Anagenex’s complete valuation and funding history, request access »

Anagenex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-2
Seed 3,500,000 $0.000010 $1 $1 1x $1 14.98%
To view Anagenex’s complete cap table history, request access »

Anagenex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an AI-driven drug discovery platform intended to develop small-molecule therapeutics. The company combines u
Drug Discovery
Lexington, MA
33 As of 2024

San Francisco, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anagenex Competitors (17)

One of Anagenex’s 17 competitors is Nurix Therapeutics, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nurix Therapeutics Formerly VC-backed San Francisco, CA
insitro Venture Capital-Backed South San Francisco, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
Relay Therapeutics Formerly VC-backed Cambridge, MA
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
You’re viewing 5 of 17 competitors. Get the full list »

Anagenex Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Anagenex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023236708-A1 Directed evolution of molecules by iterative experimentation and machine learning Pending 15-Mar-2022
EP-4494147-A1 Directed evolution of molecules by iterative experimentation and machine learning Inactive 15-Mar-2022
US-20250201336-A1 Directed evolution of molecules by iterative experimentation and machine learning Inactive 15-Mar-2022
WO-2023178118-A1 Directed evolution of molecules by iterative experimentation and machine learning Inactive 15-Mar-2022 G16B15/30

Anagenex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Anagenex FAQs

  • When was Anagenex founded?

    Anagenex was founded in 2019.

  • Where is Anagenex headquartered?

    Anagenex is headquartered in Lexington, MA.

  • What is the size of Anagenex?

    Anagenex has 33 total employees.

  • What industry is Anagenex in?

    Anagenex’s primary industry is Drug Discovery.

  • Is Anagenex a private or public company?

    Anagenex is a Private company.

  • What is Anagenex’s current revenue?

    The current revenue for Anagenex is .

  • How much funding has Anagenex raised over time?

    Anagenex has raised $37.2M.

  • Who are Anagenex’s competitors?

    Nurix Therapeutics, insitro, Exscientia, Relay Therapeutics, and Genesis Molecular AI are some of the 17 competitors of Anagenex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process